Remove 2016 Remove Cell Biology Remove Small Molecule
article thumbnail

New molecular insights on medical cannabis

Drug Target Review

2016 Jun 23;59(12):5604–21. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. The Journal of Cell Biology. Structure–Activity Relationships of Small Molecule Autotaxin Inhibitors with a Discrete Binding Mode. 2016 Sep;7(1):11248.

article thumbnail

AM-Pharma Appoints Chief Medical Officer and VP Manufacturing to Support Global Pivotal Trial in Sepsis-associated Acute Kidney Injury

The Pharma Data

At Aduro, he was responsible for all manufacturing and supply chain activities for the company’s biologics and small molecules and managed a transatlantic team. USA) from the period of 2006 to 2016. in Cell Biology from Utrecht University. Kenilworth, N.J., Dr. van de Laar holds a M.Sc. About AM-Pharma.

Trials 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

Fascinated by the potential of AI in medical research, I transitioned to BenevolentAI in early 2023 as a Biology Project Leader. There, I supported AI-enabled DD efforts in their small molecule portfolio. Driven by an interest in drug discovery Millie joined AstraZeneca after completion of her PhD at the end of 2020.

article thumbnail

Obstacles and innovations of macrocyclic drug development

Drug Target Review

Traditionally, drug discovery has focused on small-molecule therapeutics, typically with a molecular weight of less than 500 Daltons. 2 Typically, small-molecule drugs target active sites buried inside proteins. What are macrocycles and why are they interesting for drug discovery?

article thumbnail

New advances in hormone replacement therapy set to transform care

Drug Target Review

Likarda initially developed CSS to overcome the lack of effective delivery systems for cell therapies. It subsequently demonstrated promise for the administration of peptides, monoclonal antibodies and small molecules. 2016 Dec;5(6):877-884. J Endocr Soc. 2020 Oct 30;5(1):bvaa161. doi: 10.1210/jendso/bvaa161. 7] Unger CA.